Everand Logo

Welcome to Everand!

  • STAT

    STAT+: Pharmalittle: Patients brace for insurance decisions on weight loss drugs; Indian authorities find multiple problems at pharma plants

    Insurers have started aggressively cracking down on weight loss medications, which have a list price of at least $900 a month.
    by Ed Silverman Aug 03, 2023 1 minute
    Source: Alex Hogan/STAT

    Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the Pharmalot campus, where things have settled down now that the short person has left for an institution

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT1 min read
    STAT+: Freespira Bets On Slow And Steady, Amid Spectacular Digital Health Collapses
    Freespira, which makes a digital treatment for panic and post-traumatic stress disorders, expects to break even by the end of 2025.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly Lawsuits, Novo Nordisk Fires And Much More
    For the third time in a month, Novo Nordisk has been affected by an office fire. A Novo Nordisk spokesman told a local newspaper “there is nothing to suggest that…
    STAT1 min read
    STAT+: How Controversial Was The Decision By FDA’s Peter Marks To Approve Sarepta’s Gene Therapy? Check Its Footnotes
    The unilateral decision by Peter Marks, a top FDA official, to approve a gene therapy for Duchenne muscular dystrophy looks even more surprising on a close examination.

    Related Books & Audiobooks